Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Interest Expenses: 2009-2024

Historic Interest Expenses for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2024 value amounting to $10.8 million.

  • Avadel Pharmaceuticals' Interest Expenses rose 3.70% to $3.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was $12.9 million, marking a year-over-year increase of 3.72%. This contributed to the annual value of $10.8 million for FY2024, which is N/A change from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Interest Expenses stood at $10.8 million for FY2024, which was down 16.65% from $13.0 million recorded in FY2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Interest Expenses peaked at $13.0 million during FY2020, and registered a low of $10.8 million during FY2024.
  • Its 1-year average for Interest Expenses is $10.8 million, with a median of $10.8 million in 2024.
  • Data for Avadel Pharmaceuticals' Interest Expenses shows a peak YoY grew of 4.09% (in 2020) over the last 5 years.
  • Over the past 2 years, Avadel Pharmaceuticals' Interest Expenses (Yearly) stood at $13.0 million in 2020, then followed by $10.8 million in 2024.